Direct and synergistic hemolysis caused by Staphylococcus phenol-soluble modulins: Implications for diagnosis and pathogenesis

Microbes and Infection

Volumn 14, Issue 4, 2012, Pages 380-386

  Cheung, Gordon Y C ^a   Duong, Anthony C ^a   Otto, Michael ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Beta toxin; Delta toxin; Hemolysis; Phenol soluble modulin; Staphylococcus aureus; Staphylococcus epidermidis

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL TOXIN; HEMOLYSIN; PHENOL;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; MASS SPECTROMETRY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR INTERACTION; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSLATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

BACTERIAL TOXINS; HEMOLYSIN PROTEINS; HEMOLYSIS; HUMANS; NEUTROPHILS; SPHINGOMYELIN PHOSPHODIESTERASE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; VIRULENCE;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84857993562     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.11.013     Document Type: Article

References (33)

1. Lowy F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339:520-532.
2. Foster T.J. Immune evasion by staphylococci. Nat. Rev. Microbiol. 2005, 3:948-958.
3. Wiseman G.M. The hemolysins of Staphylococcus aureus. Bacteriol. Rev. 1975, 39:317-344.
4. Hebert G.A., Hancock G.A. Synergistic hemolysis exhibited by species of staphylococci. J. Clin. Microbiol. 1985, 22:409-415.
5. Doery H.M., Magnusson B.J., Cheyne I.M., Gulasekharam J. A phospholipase in staphylococcal toxin which hydrolyzes sphingomyelin. Nature 1963, 198:1091-1092.
6. Marshall M.J., Bohach G.A., Boehm D.F. Characterization of Staphylococcus aureus beta-toxin induced leukotoxicity. J. Nat. Toxins 2000, 9:125-138.
7. Gladstone G.P., Yoshida A. The cytopathic action of purified staphylococcal delta-hemolysin. Br. J. Exp. Pathol. 1967, 48:11-19.
8. Mehlin C., Headley C.M., Klebanoff S.J. An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization. J. Exp. Med. 1999, 189:907-918.
9. Wang R., Braughton K.R., Kretschmer D., Bach T.H., Queck S.Y., Li M., Kennedy A.D., Dorward D.W., Klebanoff S.J., Peschel A., DeLeo F.R., Otto M. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 2007, 13:1510-1514.
10. Rautenberg M., Joo H.S., Otto M., Peschel A. Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence. Faseb J. 2011, 25:1254-1263.
11. Vuong C., Durr M., Carmody A.B., Peschel A., Klebanoff S.J., Otto M. Regulated expression of pathogen-associated molecular pattern molecules in Staphylococcus epidermidis: quorum-sensing determines pro-inflammatory capacity and production of phenol-soluble modulins. Cell. Microbiol. 2004, 6:753-759.
12. Yao Y., Sturdevant D.E., Otto M. Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. J. Infect. Dis. 2005, 191:289-298.
13. Queck S.Y., Khan B.A., Wang R., Bach T.H., Kretschmer D., Chen L., Kreiswirth B.N., Peschel A., DeLeo F.R., Otto M. Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS Pathog. 2009, 5:e1000533.
14. Wang R., Khan B.A., Cheung G.Y., Bach T.H., Jameson-Lee M., Kong K.F., Queck S.Y., Otto M. Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. J. Clin. Invest. 2011, 121:238-248.
15. Joo H.S., Cheung G.Y., Otto M. Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives. J. Biol. Chem. 2011, 286:8933-8940.
16. Cogen A.L., Yamasaki K., Sanchez K.M., Dorschner R.A., Lai Y., MacLeod D.T., Torpey J.W., Otto M., Nizet V., Kim J.E., Gallo R.L. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J. Invest. Dermatol. 2010, 130:192-200.
17. Kretschmer D., Gleske A., Rautenberg M., Wang R., Koberle M., Bohn E., Rabiet M., Boulay F., Klebanoff S.J., Van Kessel K.P., Van Strijp J.A., Otto M., Peschel A. Human formyl peptide receptor 2 (FPR2/ALX) senses highly pathogenic Staphylococcus aureus. Cell Host Microbe 2010.
18. Traber K., Novick R. A slipped-mispairing mutation in AgrA of laboratory strains and clinical isolates results in delayed activation of agr and failure to translate delta- and alpha-haemolysins. Mol. Microbiol. 2006, 59:1519-1530.
19. Holden M.T., Feil E.J., Lindsay J.A., Peacock S.J., Day N.P., Enright M.C., Foster T.J., Moore C.E., Hurst L., Atkin R., Barron A., Bason N., Bentley S.D., Chillingworth C., Chillingworth T., Churcher C., Clark L., Corton C., Cronin A., Doggett J., Dowd L., Feltwell T., Hance Z., Harris B., Hauser H., Holroyd S., Jagels K., James K.D., Lennard N., Line A., Mayes R., Moule S., Mungall K., Ormond D., Quail M.A., Rabbinowitsch E., Rutherford K., Sanders M., Sharp S., Simmonds M., Stevens K., Whitehead S., Barrell B.G., Spratt B.G., Parkhill J. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. U S A 2004, 101:9786-9791.
20. Baba T., Takeuchi F., Kuroda M., Yuzawa H., Aoki K., Oguchi A., Nagai Y., Iwama N., Asano K., Naimi T., Kuroda H., Cui L., Yamamoto K., Hiramatsu K. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002, 359:1819-1827.
21. Diep B.A., Gill S.R., Chang R.F., Phan T.H., Chen J.H., Davidson M.G., Lin F., Lin J., Carleton H.A., Mongodin E.F., Sensabaugh G.F., Perdreau-Remington F. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006, 367:731-739.
22. Traber K.E., Lee E., Benson S., Corrigan R., Cantera M., Shopsin B., Novick R.P. agr function in clinical Staphylococcus aureus isolates. Microbiology 2008, 154:2265-2274.
23. Coleman D.C., Arbuthnott J.P., Pomeroy H.M., Birkbeck T.H. Cloning and expression in Escherichia coli and Staphylococcus aureus of the beta-lysin determinant from Staphylococcus aureus: evidence that bacteriophage conversion of beta-lysin activity is caused by insertional inactivation of the beta-lysin determinant. Microb. Pathog. 1986, 1:549-564.
24. Donvito B., Etienne J., Denoroy L., Greenland T., Benito Y., Vandenesch F. Synergistic hemolytic activity of Staphylococcus lugdunensis is mediated by three peptides encoded by a non-agr genetic locus. Infect. Immun. 1997, 65:95-100.
25. Gase K., Ferretti J.J., Primeaux C., McShan W.M. Identification, cloning, and expression of the CAMP factor gene (cfa) of group A streptococci. Infect. Immun. 1999, 67:4725-4731.
26. Wilkinson H.W. CAMP-disk test for presumptive identification of group B streptococci. J. Clin. Microbiol. 1977, 6:42-45.
27. Choudhury T.K. Synergistic lysis of erythrocytes by Propionibacterium acnes. J. Clin. Microbiol. 1978, 8:238-241.
28. Lo C.W., Lai Y.K., Liu Y.T., Gallo R.L., Huang C.M. Staphylococcus aureus hijacks a skin commensal to intensify its virulence: immunization targeting beta-hemolysin and CAMP factor. J. Invest. Dermatol. 2011, 131:401-409.
29. Adhikari R.P., Arvidson S., Novick R.P. A nonsense mutation in agrA accounts for the defect in agr expression and the avirulence of Staphylococcus aureus 8325-4 traP::kan. Infect. Immun. 2007, 75:4534-4540.
30. McNamara P.J., Iandolo J.J. Genetic instability of the global regulator agr explains the phenotype of the xpr mutation in Staphylococcus aureus KSI9051. J. Bacteriol. 1998, 180:2609-2615.
31. Villaruz A.E., Wardenburg J.B., Khan B.A., Whitney A.R., Sturdevant D.E., Gardner D.J., DeLeo F.R., Otto M. A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation. J. Infect. Dis. 2009, 200:724-734.
32. Queck S.Y., Jameson-Lee M., Villaruz A.E., Bach T.H., Khan B.A., Sturdevant D.E., Ricklefs S.M., Li M., Otto M. RNAIII-Independent target gene control by the agr quorum-sensing system: Insight into the evolution of virulence regulation in Staphylococcus aureus. Mol. Cell. 2008, 32:150-158.
33. Koenig R.L., Ray J.L., Maleki S.J., Smeltzer M.S., Hurlburt B.K. Staphylococcus aureus AgrA binding to the RNAIII-agr regulatory region. J. Bacteriol. 2004, 186:7549-7555.